Next-generation characterization of the Cancer Cell Line Encyclopedia

Joshua M. Korn | Jacob D. Jaffe | Ellen T. Gelfand | James M. McFarland | Michael P. Morrissey | Michael D. Jones | B. Haas | T. Golub | W. Hahn | G. Getz | J. Lehár | W. Sellers | G. Mills | M. Lawrence | J. Korn | Nicolas Stransky | B. Weir | L. Garraway | K. Venkatesan | F. Aguet | C. Johannessen | Judit Jané-Valbuena | M. Ghandi | Manway Liu | J. Boehm | G. Kryukov | Jaegil Kim | M. Imieliński | J. Barretina | G. Caponigro | Dmitriy Sonkin | Anupama Reddy | Michael D. Jones | R. Schlegel | R. Akbani | A. Cherniack | Yiling Lu | F. Vazquez | D. Porter | A. Kauffmann | J. Shih | J. Hess | Aviad Tsherniak | F. Stegmeier | E. McDonald | A. Lane | Y. Maruvka | J. Bistline | D. Weinstock | Mahdi Zamanighomi | P. Gokhale | Amanda L. Creech | J. Jaffe | F. Huang | C. Bielski | Allison Warren | B. Paolella | M. Rothberg | Kevin Hadi | Christopher C. Lo | Haoxin Li | K. Hu | Alexander Y. Andreev-Drakhlin | Hong L. Tiv | Antoine de Weck | Ali Amin Mansour | Coyin Oh | Yanay Rosen | J. Golji | Jordan E. Taylor | C. Dunning | Cory M. Johannessen | Levi A. Garraway | Haoxin Li | François Aguet | Yiling Lu | D. Sonkin | Mahmoud Ghandi | Franklin W. Huang | Judit Jané-Valbuena | Gregory V. Kryukov | Christopher C. Lo | E. Robert McDonald | Jordi Barretina | Ellen T. Gelfand | Craig M. Bielski | Kevin Hu | Alexander Y. Andreev-Drakhlin | Jaegil Kim | Brian J. Haas | Barbara A. Weir | Michael V. Rothberg | Brenton R. Paolella | Michael S. Lawrence | Rehan Akbani | Hong L. Tiv | Prafulla C. Gokhale | Antoine de Weck | Coyin Oh | Juliann Shih | Kevin Hadi | Yanay Rosen | Jonathan Bistline | Kavitha Venkatesan | Anupama Reddy | Dmitriy Sonkin | Manway Liu | Joseph Lehar | Joshua M. Korn | Javad Golji | Giordano Caponigro | Jordan E. Taylor | Caitlin M. Dunning | Amanda L. Creech | Allison C. Warren | Mahdi Zamanighomi | Audrey Kauffmann | Nicolas Stransky | Marcin Imielinski | Yosef E. Maruvka | Andrew D. Cherniack | Jacob D. Jaffe | Andrew A. Lane | David M. Weinstock | Cory M. Johannessen | Michael P. Morrissey | Frank Stegmeier | Robert Schlegel | Gad Getz | Gordon B. Mills | Todd R. Golub | William R. Sellers | Mike S. Lawrence | Allison C. Warren | Rehan Akbani

[1]  G. G. Galli,et al.  The landscape of cancer cell line metabolism , 2019, Nature Medicine.

[2]  O. Abdel-Wahab,et al.  Aberrant RNA Splicing in Cancer. , 2019, Annual review of cancer biology.

[3]  Joshua M. Dempster,et al.  Genetic and transcriptional evolution alters cancer cell line drug response , 2018, Nature.

[4]  G. Getz,et al.  Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair , 2018, Nature Communications.

[5]  Steven J. M. Jones,et al.  Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas , 2017, Cell.

[6]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[7]  Gad Getz,et al.  Analysis of somatic microsatellite indels identifies driver events in human tumors , 2017, Nature Biotechnology.

[8]  Phillip G. Montgomery,et al.  Defining a Cancer Dependency Map , 2017, Cell.

[9]  Antoine de Weck,et al.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening , 2017, Cell.

[10]  Ann E. Sizemore,et al.  Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells , 2017, Nature Genetics.

[11]  U. Warrior,et al.  Abstract 2116: Combining the power of different profiling approaches to better understand the activity of kinase inhibitor drugs , 2017 .

[12]  Hans Bitter,et al.  The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 , 2017, Nature.

[13]  Timothy L. Tickle,et al.  STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq , 2017, bioRxiv.

[14]  Yiling Lu,et al.  Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.

[15]  Joachim Weischenfeldt,et al.  SvABA: genome-wide detection of structural variants and indels by local assembly , 2018, Genome research.

[16]  B. Kennedy,et al.  Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing. , 2017, Cell reports.

[17]  Marc R. Birtwistle,et al.  Drug response consistency in CCLE and CGP , 2016, Nature.

[18]  Krister Wennerberg,et al.  Consistency in drug response profiling , 2016, Nature.

[19]  Nancy J. Cox,et al.  Consistency in large pharmacogenomic studies , 2016, Nature.

[20]  Emanuel J. V. Gonçalves,et al.  A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.

[21]  Ping Zhu,et al.  Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases , 2016, Nature.

[22]  Scott E. Martin,et al.  Reproducible pharmacogenomic profiling of cancer cell line panels , 2016, Nature.

[23]  R. Lothe,et al.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes , 2016, Oncogene.

[24]  Gad Getz,et al.  Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors , 2016, Nature Genetics.

[25]  T. Golub,et al.  High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines , 2016, Nature Biotechnology.

[26]  R. Campbell,et al.  Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. , 2016, The Journal of clinical investigation.

[27]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[28]  Michael P. Morrissey,et al.  Pharmacogenomic agreement between two cancer cell line data sets , 2015, Nature.

[29]  W. Hahn,et al.  TERT promoter mutations and monoallelic activation of TERT in cancer , 2015, Oncogenesis.

[30]  S. Gabriel,et al.  Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution , 2015, Nature Communications.

[31]  Steven J. M. Jones,et al.  Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.

[32]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[33]  Steven A. Carr,et al.  Building the Connectivity Map of epigenetics: chromatin profiling by quantitative targeted mass spectrometry. , 2015, Methods.

[34]  P. Sharp,et al.  Detained introns are a novel, widespread class of post-transcriptionally spliced introns , 2015, Genes & development.

[35]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[36]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[37]  Prahlad T. Ram,et al.  A pan-cancer proteomic perspective on The Cancer Genome Atlas , 2014, Nature Communications.

[38]  Benjamin Haibe-Kains,et al.  Inconsistency in large pharmacogenomic studies , 2013, Nature.

[39]  Rajiv Narayan,et al.  A melanocyte lineage program confers resistance to MAP kinase pathway inhibition , 2013, Nature.

[40]  Jacob D. Jaffe,et al.  Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia , 2013, Nature Genetics.

[41]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[42]  John L Cleveland,et al.  Targeting lactate metabolism for cancer therapeutics. , 2013, Journal of Clinical Investigation.

[43]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[44]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[45]  Lynda Chin,et al.  Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.

[46]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[47]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[48]  Zachary D. Smith,et al.  Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling , 2012, Genome Biology.

[49]  Francine E. Garrett-Bakelman,et al.  methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles , 2012, Genome Biology.

[50]  Hubing Shi,et al.  MDM4 is a key therapeutic target in cutaneous melanoma , 2012, Nature Medicine.

[51]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[52]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[53]  Chris Williams,et al.  RNA-SeQC: RNA-seq metrics for quality control and process optimization , 2012, Bioinform..

[54]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[55]  J. Downing,et al.  Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells , 2011, Nature Medicine.

[56]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[57]  Dennis C. Friedrich,et al.  A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries , 2011, Genome Biology.

[58]  A. S. Krasilnikov,et al.  Of proteins and RNA: the RNase P/MRP family. , 2010, RNA.

[59]  G. Pruijn,et al.  Heterodimerization of the human RNase P/MRP subunits Rpp20 and Rpp25 is a prerequisite for interaction with the P3 arm of RNase MRP RNA , 2010, Nucleic acids research.

[60]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[61]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[62]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[63]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[64]  W. Mercer,et al.  A Novel MDMX Transcript Expressed in a Variety of Transformed Cell Lines Encodes a Truncated Protein with Potent p53 Repressive Activity* , 1999, The Journal of Biological Chemistry.

[65]  J. Jiricny,et al.  Mismatch repair deficiency associated with overexpression of the MSH3 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.